Ontario Brain Institute
12
2
2
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
33.3%
4 terminated/withdrawn out of 12 trials
50.0%
-36.5% vs industry average
8%
1 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Comprehensive Assessment of Neurodegeneration and Dementia
Role: collaborator
Holly™ Community Trial
Role: collaborator
A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome
Role: collaborator
Light and Ion Maintenance In Treatment for Depression (LIMIT-D): Feasibility Study
Role: collaborator
Health in Aging, Neurodegenerative Diseases and Dementias In Ontario
Role: collaborator
Clinic to Community© Program for Adults With Epilepsy Admitted to Emergency Departments
Role: collaborator
Innovative Robotic Gait Trainer Use to Enable Walking in Children With Cerebral Palsy GMFCS III and IV
Role: collaborator
Video Game for Home-based Rehabilitation for Children With Hemiplegia
Role: collaborator
Clinical Trial of the Effects of DHA in the Treatment of Seizure Disorders
Role: collaborator
Cannabis Extract in Refractory Epilepsy Study
Role: collaborator
Cognitive Restructuring in ADHD: Functional Training
Role: collaborator
STEP: Enhanced Physical Activity in Children and Youth With Epilepsy
Role: collaborator
All 12 trials loaded